Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3972-3979

  Christiansen, Erik ^a   Tibell, Annika ^b   Vølund, Aage ^c   Rasmussen, Knud ^d   Groth, Carl Gustav ^b   Holst, Jens Juul ^e   Pedersen, Oluf ^a   Christensen, Niels Juel ^d   Madsbad, Sten ^d  

^a STENO DIABETES CENTER   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN;

ADULT; ARTICLE; CADAVER; CELL SECRETION; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; ARGININE; BLOOD GLUCOSE; FEMALE; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION;

ZEA MAYS;

EID: 0029819930     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3972     Document Type: Article

References (44)

1. Diem P, Abid M, Redmon JB, Sutherland DER, Robertson RP. 1990 Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type 1 diabetic recipients. Diabetes. 39:534-540.
2. Blackman JD, Polonsky KS, Jaspan JB, Sturis J, Cauter EV, Thistlethwaite RJ. 1992 Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 41:1346-1354.
3. Osei K, Henry ML, O'Dorisio TM, Tesi RJ, Sommer BG, Ferguson RM. 1990 Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type 1 diabetic pancreas allograft recipients. Diabetes. 39:1235-1242.
4. Katz H, Homan M, Velosa J, Robertson P, Rizza R. 1991 Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med. 325:1278-1283.
5. Christiansen E, Andersen HB, Rasmussen K, et al. 1993 Pancreatic β-cell function and glucose metabolism in human pancreas and kidney transplantation. Am J Physiol. 264:E441-E449.
6. Teuscher AU, Seaquist ER, Robertson RP. 1994 Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes. 43:593-598.
7. Seaquist ER, Robertson RP. 1992 Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest. 89:1761-1766.
8. Palmer JP, Walet RM, Ensinck JW. 1975 Arginine-stimulated acute phase of insulin and glucagon secretion in normal man. Diabetes. 24:735-740.
9. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
10. Cerasi E. 1975 Potentiation of insulin release by glucose in man. Acta Endocrinol (Copenh). 79:511-534.
11. Grill V. 1981 Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol. 240:E24-E31.
12. Heding LG. 1975 Specific and direct radioimmunoassay for human C-peptide in serum. Diabetologia. 11:547-548.
13. Heding LG. 1972 Determination of total serum insulin (IRI) in insulin treated diabetic patients. Diabetologia. 8:260-266.
14. Östman J, Amer P, Groth CG, Gunnarsson R, Heding L, Lundgren G. 1986 Plasma C-peptide and serum insulin binding antibodies in diabetic patients receiving pancreatic transplants. Diabetologia. 19:25-30.
15. Holst JJ. 1980 Evidence that glicentin contains the entire sequence of glucagon. Biochem J. 187:337-343.
16. Halter J, Graf RJ, Porte Jr D. 1979 Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab. 48:946-954.
17. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte Jr D. 1984 Diminished B-cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest. 74:1318-1328.
18. Ward WK, Wallum BJ, Beard JC, Taborsky GJ, Porte Jr D. 1988 Reduction in glycemic potentiation. Sensitive indicator of β-cell loss in partially pancreatectomized dogs. Diabetes. 37:723-729.
19. Christiansen E, Tibell A, Groth CG, et al. 1994 Limitations in the use of insulin or C-peptide alone in the assessment of β-cell function in pancreas transplant recipients. Transplant Proc. 26:467-468.
20. Vølund Aa, Polonsky KS, Bergman RN. 1987 Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes. 36:1195-1202.
21. Porte Jr D. 1991 β-Cells in type II diabetes mellitus. Banting Lecture 1990. Diabetes. 40:166-180.
22. Tillil H, Shapiro T, Rubenstein AH, Galloway JA, Polonsky KS. 1988 Reduction of insulin clearance during hyperglycemic clamp. Dose response study in normal humans. Diabetes. 37:1351-1357.
23. Rudenski AS, Hosker JP, Burnett MA, Matthews DR, Turner RC. 1988 The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates. Metabolism. 37:526-534.
24. Swinburn BA, Gianchandani R, Saad MF, Lillioja S. 1995 In vivo β-cell function at the transition to early non-insulin-dependent diabetes mellitus. Metabolism. 44:757-764.
25. 256Lys mutation. Diabetes. 43:1402-1406.
26. Kahn SE, Beard JC, Schwartz MW, et al. 1989 Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes. 38:562-568.
27. Tobin BW, Lewis JT, Tobin BL, Rajotte RV, Finegood DT. 1992 Markedly reduced β-cell function does not result in insulin resistance in islet autografted dogs. Diabetes. 41:1172-1181.
28. Van Haeften TW, Van Maarschalkerweerd WWA, Gerich JE, Van der Veen EA. 1991 Decreased insulin secretory capacity and normal pancreactic B-cell glucose sensitivity in non-obese patients with NIDDM. Eur J Clin Invest. 21:168-174.
29. Puejo M, Clement K, Vaxillaire M, et al. 1994 Arginine-induced insulin release in glucokinase-deficient subjects. Diabetes Care. 17:1015-1021.
30. Leahy JL, Bumbalo LM, Chen C. 1993 Beta-cell hypersensitivity to glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats. Diabetologia. 36:1238-1244.
31. Orland MJ, Permutt MA. 1991 Comparative modulations of insulin secretion, pancreatic insulin contents, and proinsulin mRNA in rats. Effects of pancreatectomy and dexamethasone administration. Diabetes. 40:181-189.
32. Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP. 1990 Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med. 322:898-903.
33. Christiansen E, Tibell A, Velund Aa, et al. 1994 Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients. J Clin Endocrinol Metab. 79:1561-1569.
34. Kahn SE, Prigeon RL, McCulloch DK, et al. 1994 The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes. 43;587-592.
35. Bergman RN. 1989 Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes. 38:1512-1527.
36. Grill V, Alvarsson M, Efendic S. 1992 Dexamethasone treatment fails to increase arglnine-induced insulin release in healthy subjects with low insulin response. Diabetologia. 35:367-371.
37. Luzi L, Secchi A, Facchini F, et al. 1990 Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia. 33:549-556.
38. Elahi D, Clark BA, McAloon-Dyke M, et al. 1991 Islet cell responses to glucose in human transplanted pancreas. Am J Physiol. 261:E800-E808.
39. Ekstrand AV. 1991 Effect of steroid-therapy on insulin sensitivity in insulin-dependent diabetic patients after kidney transplantation. J Diabetes Complications. 5:244-248.
40. Yamamoto A, Akazawa S, Yamaguchi Y, et al. 1991 Effects of cyclosporin A and low dosages of steroid on posttransplant diabetes in kidney transplant recipients. Diabetes Care. 14:867-870.
41. Pagano G, Cavallo-Perin P, Cassader B, Bruno A, Ozzello A, Masciola P. 1983 An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 72:1814-1820.
42. Rizza RA, Mandarino LJ, Gerich JE. 1982 Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab. 54:131-138.
43. Piatti PM, Pontiroli AE, Caumo A, et al. 1994 Hyperinsulinemia decreases second-phase but not first-phase arginine-induced insulin release in humans. Diabetes. 43:1157-1163.
44. Asplin CM, Paquettte TL, Palmer JP. 1981 In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest. 68:314-318.